MedPath

DIBAN CAP

DIBAN CAP

Discontinued
DIN Number

01909215

Drug Class

Human

Market Date

Dec 31, 1992

Company
HC

ayerst laboratories

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number01909215
AIG Number0602321001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Narcotic (CDSA I)
A
ATC Code
A07DA02 OPIUM
Product Specifications
Dosage FormCapsule
Route of AdministrationOral
AHFS Classification56:08.00
Health Canada Classification

ACTIVE INGREDIENTS (6)

ATROPINE SULFATEActive
Strength: 9.7 MCG
Monograph: ATROPINE SULFATE
ATTAPULGITE (ACTIVATED)Active
Strength: 300 MG
Monograph: ATTAPULGITE (ACTIVATED)
HYOSCYAMINE SULFATEActive
Strength: 0.0519 MG
Monograph: HYOSCYAMINE SULFATE
OPIUMActive
Strength: 12 MG
Monograph: OPIUM
PECTINActive
Strength: 71.4 MG
Monograph: PECTIN
SCOPOLAMINE HYDROBROMIDEActive
Strength: 3.3 MCG
Monograph: SCOPOLAMINE HYDROBROMIDE

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.